Selpercatinib monotherapy in a Chinese patient with RET fusion/EGFR co-mutated nonsmall cell lung cancer from the Phase II LIBRETTO-321 study: a case report.

Details

Language :

English

ISSN :

09594973

Volume :

34

Issue :

9

Database :

Complementary Index

Journal :

Anti-Cancer Drugs

Publication Type :

Academic Journal

Accession number :

172434564

Full Text :

https://doi.org/10.1097/cad.0000000000001527